No images? Click here
HealthPlatform.News(letter)
November 17, 2025
In this week’s edition of health news across the states: Trump’s drug price deal to bring relief to the states, Ohio bill among several in the nation seeking to expand the role of optometrists, New effort to bring drug production back to the U.S. gains steam
Plus: Crowley, Biotechnology Innovation Organization: Spurring innovation in the biotech industry will save lives
Patients struggling with obesity will have greater access to the drugs that can help them, at a much lower cost.
A bill that would allow optometrists to perform certain procedures that currently only ophthalmologists are permitted to undertake is making its way through the Ohio General Assembly.
The Trump Administration is moving to speed generic drug approvals and bring more drug manufacturing back to U.S. soil — an effort to cut red tape, lower prices and reduce reliance on China and India.
Twenty-five years ago, my two youngest children, Megan and Patrick, were diagnosed with Pompe disease, a rare and fatal neuromuscular disorder. At the time, there was no treatment — no hope beyond comfort care. I left my job, went back to graduate school, and eventually helped start a small biotech company dedicated to developing an enzyme replacement therapy.
Support HealthPlatform.News
by contributing to our nonprofit news operation.
Did someone forward this to you?
